Osteoblast-Derived Erythroferrone Regulates Stress Erythropoiesis

A recent study published in the Proceedings of the National Academy of Sciences (PNAS) reveals that erythroferrone (ERFE) derived from osteoblasts plays a critical role in regulating stress erythropoiesis. The research highlights that bone marrow ERFE suppresses hepcidin, a key regulator of iron homeostasis, by sequestering bone morphogenetic proteins (BMPs). This mechanism significantly increases iron availability, which is essential for the production of red blood cells during periods of physiological stress. Building on previous findings that identified osteoblasts as a source of ERFE involved in bone control, this new evidence establishes a direct link between skeletal cells and hematopoietic processes. The discovery underscores the complex interplay between the skeletal system and iron metabolism, offering new insights into how the body adapts to increased demands for erythropoiesis. These findings have potential implications for understanding and treating disorders related to iron deficiency and anemia, particularly those associated with chronic inflammation or bone marrow stress. The study contributes to the broader scientific understanding of systemic iron regulation and the multifunctional role of osteoblasts beyond bone formation.